Arachidonate 5-lipoxygenase (ALOX5) expression and activity has been implicated in tumor pathogenesis, yet its role in papillary thyroid carcinoma (PTC) has not been characterized. ALOX5 protein and mRNA were upregulated in PTC compared to matched, normal thyroid tissue, and ALOX5 expression correlated with invasive tumor histopathology. Evidence suggests that PTC invasion is mediated through the induction of matrix metalloproteinases (MMPs) that can degrade and remodel the extracellular matrix (ECM). A correlation between MMP-9 and ALOX5 protein expression was established by immunohistochemical analysis of PTC and normal thyroid tissues using a tissue array. Transfection of ALOX5 into a PTC cell line (BCPAP) increased MMP-9 secretion and cell invasion across an ECM barrier. The ALOX5 product, 5(S)-hydroxyeicosatetraenoic acid also increased MMP-9 protein expression by BCPAP in a dose-dependent manner. Inhibitors of MMP-9 and ALOX5 reversed ALOX5-enhanced invasion. Here we describe a new role for ALOX5 as a mediator of invasion via MMP-9 induction; this ALOX5/MMP9 pathway represents a new avenue in the search for functional biomarkers and/or potential therapeutic targets for aggressive PTC.
A number of gene transcripts were differentially expressed by the cell lines assayed. Among them, FMOD was further evaluated in clinical samples and was found to be differentially expressed between benign and prostate cancer tissue. Further validation of FMOD transcript in a larger population is required to ascertain its usefulness as biomarker for prostate cancer.
Age-associated alterations in the gene expression profile may put the aging prostate in risk for the initiation, promotion, and progression of neoplastic transformation in both our animal model and humans.
Spinal cord injury (SCI) affects thousands of people each year and there are no treatments that dramatically improve clinical outcome. Canine intervertebral disc herniation is a naturally-occurring SCI that has similarities to human injury and can be used as a translational model for evaluating therapeutic interventions. Here, we characterized cerebrospinal fluid (CSF) acute phase proteins (APPs) that have altered expression across a spectrum of neurological disorders, using this canine model system. The concentrations of C-reactive protein (CRP), haptoglobin (Hp), alpha-1-glycoprotein, and serum amyloid A were determined in the CSF of 42 acutely injured dogs, compared with 21 healthy control dogs. Concentrations of APPs also were examined with respect to initial injury severity and motor outcome 42 d post-injury. Hp concentration was significantly higher (p<0.0001) in the CSF of affected dogs, compared with healthy control dogs. Additionally, the concentrations of CRP and Hp were significantly (p=0.0001 and p=0.0079, respectively) and positively associated with CSF total protein concentration. The concentrations of CRP and Hp were significantly higher (p=0.0071 and p=0.0197, respectively) in dogs with severe injury, compared with those with mild-to-moderate SCI, but there was no significant correlation between assessed CSF APP concentrations and 42 d motor outcome. This study demonstrated that CSF APPs were dysregulated in dogs with naturally-occurring SCI and could be used as markers for SCI severity. As Hp was increased following severe SCI and is neuroprotective across a number of model systems, it may represent a viable therapeutic target.
Introducción. El glifosato es un herbicida de amplio espectro, no selectivo, utilizado comúnmente en agricultura para eliminar malezas. Los estudios que han evaluado la toxicidad del glifosato en animales y en ambiente muestran que las formulaciones comerciales son más tóxicas que el componente activo. Objetivos. Evaluar la toxicidad del glifosato grado técnico y de la formulación comercial Roundup® en células mononucleares de sangre periférica humana. Materiales y métodos. Células mononucleares de sangre periférica humana fueron expuestas a diferentes concentraciones de glifosato en grado técnico y en la forma de Roundup® por 24, 48, 72 y 96 horas. La citotoxicidad se evaluó mediante el método de exclusión con azul de tripano y reducción del reactivo sal sódica de (2,3-bis[2-metoxi-4-nitro-5-sulfofenil]-2Htetrazolio-5-carboxianilida) (XTT). Resultados. Ambas presentaciones del glifosato (grado técnico y Roundup®) fueron tóxicas para las células mononucleares de sangre periférica humana. Roundup® fue más citotóxico que el glifosato grado técnico, ya que se encontró que la concentración letal 50 (LC 50 ) analizada con el método de exclusión con azul de tripano a las 24 horas fue de 56,4 µg/ml de glifosato en la forma de Roundup® y de 1.640 mg/ml (1,64 µg/ml) para glifosato grado técnico. Conclusiones. Los resultados de este estudio in vitro confirman el efecto tóxico para las células humanas observado para el glifosato y sus preparaciones comerciales, y que estas últimas son más citotóxicas que el compuesto activo, lo que apoya la idea de que los aditivos presentes en las formulaciones comerciales juegan un papel crucial en la toxicidad atribuida a los herbicidas que contienen glifosato.Palabras clave: pruebas inmunológicas de citotoxicidad, herbicidas, células sanguíneas, supervivencia celular, azul de tripano, sales de tetrazolio. Cytotoxicity of the herbicide glyphosate in human peripheral blood mononuclear cellsIntroduction. Glyphosate is a broad-spectrum, non-selective herbicide and commonly used to eliminate weeds in agricultural and forest settings. Studies evaluating glyphosate toxicity in animals and environment show that commercial formulations of glyphosate are more toxic than the active component itself. Objectives. Technical grade glyphosate was compared with the commercial formulation Roundup® in their respective toxicities on human peripheral blood mononuclear cells. Materials and methods. Human peripheral blood mononuclear cells were exposed to different concentrations of glyphosate, either technical grade or in the form of Roundup for 24 h, 48 h, 72 h, and 96 h. Cytotoxicity was assayed by trypan blue dye exclusion method and reduction of (2,3-bis[2-methoxy-4-nitro-5-sulfophenyl]-2Htetrazolium-5-carboxyanilide inner salt) XTT reagent. Results. Both technical grade glyphosate and Roundup® formulation were toxic to human peripheral blood mononuclear cells. Cytotoxicity of Roundup® was higher than cytotoxicity of glyphosate, since the LC 50 (50% lethal concentration) determined by the trypan blue ex...
Background: The hallmark of tuberculosis is the granuloma, an organized cellular accumulation playing a key role in host defense against Mycobacterium tuberculosis. These structures sequester and contain mycobacterial cells preventing active disease, while long term maintenance of granulomas leads to latent disease. Clear understanding on mechanisms involved in granuloma formation and maintenance is lacking.Objective: To monitor granuloma formation and to determine gene expression profiles induced during the granulomatous response to M. tuberculosis (H37Ra). Methods:We used a previously characterized in vitro human model. Cellular aggregation was followed daily with microscopy and Wright staining for 5 days. Granulomas were collected at 24h, RNA extracted and hybridized to Affymetrix human microarrays. Resultados: Se observó la formación gradual de granulomas en respuesta a la infección. Los granulomas persistieron por 96 h, y luego se desvanecieron.Conclusiones: Se identificaron genes de la respuesta inmune innata y vías de presentación antigénica activadas durante la respuesta granulomatosa in vitro a células micobacteriales vivas, lo cual reveló alteraciones tempranas de la expresión génica en el inicio de la respuesta granulomatosa humana. Original Article Microarray analysis of the in vitro granulomatous response to Mycobacterium tuberculosis H37RaAnálisis con Micromatrices de la respuesta granulomatosa in vitro a Mycobacterium tuberculosis H37Ra
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.